background: Human trophoblast invasion and differentiation are essential for a successful pregnancy outcome. Dysregulation of these processes can lead to placental pathologies such as pre-eclampsia. The molecular mechanisms; however, are poorly understood. Interleukin (IL)11-a cytokine that regulates endometrial epithelial cell adhesion, trophoblast motility and invasion during implantation-may be involved in some of these processes.
Introduction
The process of trophoblast differentiation and subsequent invasion is essential for placental development and pregnancy success. During early stages of gestation, extravillous trophoblasts (EVTs), differentiated from proliferative cell column cytotrophoblasts of anchoring villi, invade the stroma and arterial vessels of the maternal decidua. This differentiated cell type remodels the uterine arteries to increase vessel diameter and conductivity to initiate and maintain blood flow into the placenta (Pijnenborg et al., 1983) . Failures in the differentiation and invasion process are associated with severe gestational diseases. Intrauterine growth retardation and pre-eclampsia (PE) are associated with limited invasion and incomplete transformation of spiral arteries (Pijnenborg et al., 1991; Norwitz, 2007) .
Interleukin (IL) 11 is one of a very the few molecules shown to be critical for endometrial receptivity and embryo implantation (Paiva et al., 2009a,b; Dimitriadis et al., 2010; Menkhorst et al., 2010) . IL11 is also one of few molecules known to be absolutely required for mouse blastocyst implantation (Stewart et al., 1992; Bilinski et al., 1998; Robb et al., 1998) . Female mice with a null mutation of the IL11-receptor (R)a are infertile due to a defective postimplantation response to the implanting blastocyst, leading to unregulated trophoblast invasion and pregnancy loss. In humans, evidence also supports the importance of IL11 in the initial attachment of the blastocyst . IL11 is a member of the IL6 family of cytokines and signals via a heterodimeric complex of IL11 (R)a and gp130 (Heinrich et al., 1998) . In trophoblasts, signaling primarily acts through the janus kinase/signal transducers and activators of transcription (JAK/STAT) signal transduction pathway (Paiva et al., 2007) . IL11 also promotes the formation of active GTP-bound Ras and induces activation of mitogen-activated protein kinases (MAPKs) (Wang et al., 1995) , leading to cross-talk between Ras-MAPK and JAK/STAT signaling pathways in different cell types (Wang et al., 1995; Fitzgerald et al., 2005) .
Our group recently observed that contrary to its positive effect on enhanced attachment during implantation, IL11 inhibits EVT invasion via STAT3 activation during early placentation (Paiva et al., 2009a,b) . The details, however, on the molecular mechanism remain elusive.
To gain insight into IL11-regulated trophoblast motility, we compared the protein profiles of IL11-treated and untreated human EVT cells by two-dimension (2D)-differential in-gel electrophoresis (DIGE) and identified the differentially expressed proteins by mass spectrometry (MS). This is the first study that used a proteomic approach to define the mechanisms by which IL11 regulates the proteome of invasive trophoblasts.
Materials and Methods

Collection of placental tissues
Placental samples were collected from healthy women undergoing firsttrimester suction termination of pregnancy (6 -10 weeks) for psychosocial reasons. Tissues were washed in 0.9% saline before transfer to medium Dulbecco's modified Eagle's medium (DMEM)/F12 1:1 (Invitrogen, Victoria, Australia). Informed consent was obtained from all participating patients. Ethics approval was granted by the Southern Health Human Research and Ethics committee.
First-trimester villous explant culture
Small pieces (1 × 1 mm) of villous tissue of first-trimester placentas (n ¼ 5) were dissected under the microscope and cultured overnight in serum-free medium (DMEM/Ham's F12). To analyze the effects of IL11 on trophoblast outgrowth, villous explants were seeded into 48-well plates for 3 h on collagen I (serum-free medium), allowing anchorage, and then stimulated with recombinant human (rh) IL11 (100 ng/ml) (carrier-free; R&D Systems Incorporated, MN, USA). After 48 h, anchoring villi (.5 per treatment group) were photographed. The area of outgrowth was measured and quantified using the imaging software Adobe Photoshop (Adobe, CA, USA).
Cell culture of primary EVTs
EVT of first-trimester placentas (n ¼ 5) were isolated by adapted enzymatic dispersion and Percoll (10 -70%) density gradient centrifugation using a previously established protocol (Tarrade et al., 2001) . Briefly, firsttrimester placental tissue was washed with ice-cold phosphate-buffered saline (PBS) and Hanks' balanced salt solution; villous tips were scraped with a scalpel blade and digested for 15 min in 0.125% trypsin (Life Technologies, Inc., Rockville, MD, USA), 1% desoxyribonuclease I (Sigma) in Mg/Ca-free Hanks' balanced salt solution (Sigma). After percolation through a cell strainer (100 mm; Greiner, Kremsmünster, Australia), a cell suspension was transferred on a Percoll gradient. Cell populations between the 35 and 50% layer were collected and seeded in 6-well plates coated with growth-factor-reduced Matrigel (1:10-100 diluted in serum-free DMEM/Ham's F12, Becton Dickinson, Franklin Lakes, NJ, USA). Cells were also seeded on chamber slides to check for trophoblast cell purity by immunostaining with antibodies against cytokeratin-7 (epithelial cell marker; CK7 clone OV-TL 12/30, 8.3 mg/ml; Dako, Glostrup, Denmark) and Vimentin (stromal cell marker; clone Vim 3B4, 1.2 mg/ml; Dako). Isolated cells were positive for cytokeratin-7 (.97%) and largely negative for vimentin (,3%) as previously described (Tapia et al., 2008) . Isolated cells were seeded in 6 wells at a density of 1 × 10 5 cells/cm 2 and cultivated in 1 ml DMEM/F-12 with 10% fetal calf serum (FCS) (SAFC Biosciences, Victoria, Australia).
Cell culture of HTR-8/SVneo human cells
The HTR-8/SVneo trophoblast cell line exhibits features of invasive trophoblasts cells, such as human leukocyte antigen-G (EVT marker) and cytokeratin-7 expression (routinely tested in our laboratory). These cells were cultivated in RPMI 1640 (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% FCS as previously described (Graham et al., 1993 Sample preparation and protein extraction HTR-8/SVneo cells were cultured in T75 flasks and following treatment, were washed three times in ice-cold PBS and lysed in 1 ml of 2D buffer A (urea 7 M, thiourea 2 M, Tris 40 mM, C7BzO 1% w/v). Insoluble cell debris was pelleted at 48C (55 000g, 30 min). Each sample was reduced and alkylated at room temperature, and the resulting supernatants were precipitated in 10 volumes of acetone for 90 min at room temperature. Precipitated protein was recovered by centrifugation at room temperature (10 000g, 20 min, Beckman JS 7.5 rotor). Acetone was completely removed and the pellets dried before resuspension in labeling buffer (urea 7 M, thiourea 2 M, Tris/HCl 30 mM, C7BzO 1% w/v, pH 8.5 at 48C). Protein concentration was determined using Bradford assay. Each sample was adjusted to a concentration of 5 mg/ml and pH 8.5 at room temperature, snap-frozen on dry ice and stored at 2808C until use.
Expression analysis and protein identification
2D DIGE image analysis and protein identification were carried out as previously described (Chen et al., 2009) . Protein aliquots 50 mg from each individual experiment (n ¼ 6) were labeled with Cy3 (control), Cy5 (IL11 treated) or Cy2 (mixed internal standard) and combined as recommended by the manufacturer (GE Healthcare Bioscience, Uppsala, Sweden). Isoelectric focusing was carried out using 24 cm pH 4 -7 gradients according to the following parameters: constant 60 mA per strip, 100 V/1.5 h, 300 V/1.5 h, 500 V/3 h, gradient to 1000 V/4 h, gradient to 8000 V/3 h, constant 8000 V until reaching 65 000 Vh. Second dimension separation was carried out in an 8 -16% acrylamide gradient overnight at a constant 50 V using a BioRad Dodeca electrophoresis tank. Differential expression analysis based on normalized spot volumes was carried out using PG240 SameSpots software (Nonlinear Dynamics, Newcastle-upon-Tyne, UK). Reciprocal labeling experiments were also carried out (DyeSwap) using pooled protein samples, and any proteins showing differential labeling effects specific to the use of the Cy3/Cy5 dyes were eliminated from the analysis.
Protein identification by MS
Protein spots of interest were excised from the gel using a ProPicII robotic spot picker (Genomic Solutions, MI) based on X-Y coordinates exported directly from PG240 SameSpots. Protein identification by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) and MS/MS was carried out as previously described (Chen et al., 2009; Stephens et al., 2010) . Monoisotopic peak masses were automatically extracted using GPS Explorer software (v3.0 build 311; Applied Biosystems, CA, USA) and peak lists searched against no redundant UniProtKB/ Swiss-Prot database (release 56.2; 20 407 human sequence entries; http://www.uniprot.org) using the MASCOT search engine (updated 3 January 2007; http://matrixscience.com). The species was restricted to Homo sapiens, carbonylamide-cysteine (cell adhesion molecule, fixed modification) and oxidation of methionine (variable modification) were taken into account and a parent ion mass tolerance of 50 ppm and 1 missed cleavage (trypsin) was allowed. Up to 10 of the most intense peptides detected in each MS scan were automatically selected for MS/MS analysis. Peak lists were extracted using Data Analysis software version 3.4 (Bruker Diagnostics, Germany). The parameters used to create the peak list (version 1.1, Matrix Science) were a mass range of 700 -5000 Da and signal-to-noise threshold of five, against the UniProtKB/ Swiss-Prot database as mentioned earlier, with fragment mass tolerance of 0.1 Da. Protein identities were assigned using the following criteria to evaluate the search; MOWSE score, number and intensity of peptides matched, and direct correlation between the identified protein, its estimated molecular mass and pI were determined from the 2D gel.
and 2D western blotting
Cells were grown to confluence (for HTR-8/SVneo cells) or seeded in 6-well plates at a density of 1 × 10 5 cells/cm 2 (for primary EVT), serumstarved for 24 h and treated with rhIL11 at 100 ng/ml or vehicle (0.1% BSA in PBS) for 24 h. Cells were then washed with ice-cold PBS and lysed in ice-cold lysis buffer (50 mM Tris base, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 25 mM NaF and 25 mM b-glycerolphosphate; pH 7.5, 2 ml/ ml protease inhibitor cocktail set; Calbiochem). Cellular lysates were centrifuged (maximum speed bench top centrifuge, 15 min) and the supernatant containing protein was quantified by Bradford assay. HTR-8/SVneo cells and EVT-conditioned media (CM) were also collected prior to washing step with ice-cold PBS. EVT CM was concentrated approximately 10 times using Amicon Ultra-15 30 K centrifugal filter devices (Millipore, Billerica, USA). Equal amounts of cellular and secreted protein per sample were resolved on 8 -10% sodium dodecyl sulfate (SDS) -polyacrylamide gel electrophoresis (PAGE) gels, transferred to polyvinyl difluoride (PVDF) membranes (GE Healthcare Bio-Sciences, NJ, USA), blocked with 5% non-fat dry milk in Tris-buffered saline (TBS) with 0.1% Tween-20 (Bio-Rad) and probed with polyclonal antibodies against glucose-regulated protein 78 (GRP78; 1:1000, NT-20, Biotechnology Inc., Santa Cruz, CA, USA) or glyceraldehyde-3-phosphatedehydrogenase (GAPDH)/b-actin (1:2500, Cell Signaling Inc., USA) overnight at 48C, followed by three wash steps. Membranes were incubated 1 h at room temperature with secondary antibodies (anti-goat or anti-rabbit immunoglobulin G (IgG) horse-radish peroxidase (HRP) linked, 1:5000; DakoCytomation) and signals were developed with enhanced chemiluminescence western blotting detection system reagent (Pierce). Membranes were stripped and incubated with anti-GAPDH/b-actin as a protein loading control. 2D western blotting was performed using samples prepared for the 2D-DIGE procedure as already outlined. In brief, after isoelectric focusing using 11 cm, pH 4 -7 IPG strips (ReadyStrip TM , Biorad, CA, USA), proteins were separated (2D) in a 4 -12% gradient Bis-Tris polyacrylamide gel using 2-(N-morpholino)ethanesulfonic acid buffer (Invitrogen, Carlsbad, USA) at 200 V for 1 h, and then transferred to PVDF membrane (antibody incubation and detection as above).
Immunohistochemistry for GRP78
Paraffin sections (3 mm) were dewaxed in histosol, dehydrated in a graded series of ethanol and then microwaved at high power (700 W) in 0.01 M citric acid buffer (pH 6.0) for 5 min. Endogenous peroxidase activity was quenched with 6% H 2 O 2 in 100% methanol (1:1 v/v) for 10 min in the dark at room temperature. Non-specific binding was blocked by incubating tissues with non-immune blocking solution of 10% normal horse serum and 2% normal human serum, diluted in 1× TBS for 30 min. Primary antibodies were diluted 1:100 (GRP78; Santa Cruz, CA, USA) and 1:500 (CK7) in blocking solution and applied overnight at 48C. Antibody localization was detected by sequential application of biotinylated horse anti-goat IgG (1:200 in blocking solution) for 30 min and an avidin-biotin complex conjugated to HRP (Vectastain ABC Elite kite; Vector Laboratories, Burlingame, CA, USA), before the addition of a substrate, diaminobenzidine (Zymed, San Francisco, CA, USA) which forms an insoluble brown precipitate. Negative isotype controls of non-immunized rabbit IgG (Dako) were substituted at a matching concentration to the primary antibody and included for every tissue section.
Statistical analysis
Statistical analyses of proteomic data were performed by the PG240 SameSpots software. Data are provided as mean normalized spot volume + standard deviation or SEM as specified. Statistical analysis of immunoblotting results was carried out using GraphPad Prism (GraphPad Sowftare Inc., CA, USA), and the data were assessed by Student's t-test assuming normal distribution or Kolmogorov-Smirnov test. Results of P , 0.05 were considered statistically significant.
Results
IL11 treatment decreased trophoblast outgrowth of EVT
First-trimester villous explants were cultured on collagen as a model of trophoblast motility. Explants treated with IL11 (100 ng/ml) inhibited EVT outgrowth by 53 + 11% (P , 0.05) compared with controls ( Fig. 1) . To identify possible mechanisms by which IL11 altered EVT outgrowth, we used a proteomic approach to identify IL11 target proteins.
Proteomic profile of IL11-treated HTR-8/SVneo cells 2D DIGE was used to comparatively assess protein production between whole cell lysates of HTR-8/SVneo cells treated with IL11 or vehicle control ( Fig. 2A) . Principal component analysis (PCA) of all spots revealed distinct clusters corresponding to the IL11 treatment and vehicle control groups, indicating differential protein production (Fig. 2B) . Individual protein spots displaying significant fold changes in expression (P , 0.05; analysis of variance) were considered to be present at altered levels. The results of the proteomic expression analyses are summarized in Table I . Seven hundred and thirty one differentially regulated spots were observed between IL11 and vehicle control treated groups, with the majority of these showing increased abundance in IL11-treated cells compared with control (Table I) . Differentially abundant proteins between IL11-treated and control were chosen and submitted for identification by MS based on the following criteria: fold change of ≥1.4, spot volume of ≥30 000 (arbitrary units, prior experimentation showed that spot volumes less than 30 000 were difficult to identify (unpublished data) and cross reference to the ability to visualize the spot on the gel. Of a total of 15 protein spots analyzed ( Fig. 2A) , 14 unique proteins were identified and 4 spots yielded a mixture of two or more proteins (Table II, spot numbers refer to Fig. 2A ). Eight out of these 15 protein spots remained unidentified following MS analysis and were not examined further. Of the 14 unique proteins, 2 looked promising: PDIA3 and GRP78. The other identified proteins that were not further investigated were: TUBB, TUBA1C, TUBB2C, TUBB2B and TUBB3 (like all tubulins, these are major constituents of microtubules) ZNF670 (which may be involved in transcriptional regulation) (UniProtKB/ Swiss-Prot); 14-3-3 protein theta and 14-3-3 protein zeta/delta (which are adapter proteins implicated in the regulation of signaling pathways) (Van Der Hoeven et al., 2000); RBM4 and hnRNP (which may play roles in pre-mRNA processing) (Gulesserian et al., 2003) ; HisRS (which may be involved in protein biosynthesis) (Wakasugi and Schimmel, 1999) and FKBP4 (which may play a role in intracellular trafficking) (Galigniana et al., 2010) . Their specific roles in trophoblast invasion and differentiation in regard of IL11 stimulation are not yet known.
Expression of target proteins PDIA3 and GRP78
Using DIGE, we identified two single protein spots corresponding to GRP78 and PDIA3. PDIA3 was decreased in IL11-treated HTR-8/ SVneo cells (Supplementary data, Spot S2; Table II and Fig. 2A) compared with control. Total PDIA3 abundance was then assessed by western blotting in HTR-8/SVneo and primary EVT (Fig. 3A) . PDIA3 was observed as a band of 57 kDa and was decreased by 66 + 11.4% in IL11-treated primary cells compared with diluent control-treated primary cells (set to 100%) (Fig. 3B) . Total GRP78 abundance, assessed by western blotting, showed no change in total protein abundance in IL11-treated HTR-8/SVneo cells and in EVT compared with their respective controls (Fig. 3C , n ¼ 3), contrasting with the increased abundance observed by 2D DIGE in HTR-8/SVneo cells (Supplementary data, Spot S1; Table II and Fig. 2A ). This suggested a post-translational modification of GRP78 in EVT.
Immunohistochemical staining of first-trimester placental bed tissuesections revealed staining for GRP78 in the decidual stroma and in EVT cells (EVT; positive for CK7) (Fig. 4) .
Validation of GRP78 as an IL11 target protein
To confirm our 2D-DIGE observation that IL11 regulated GRP78 protein, we performed 2D western blotting on pooled cell lysates from both HTR-8/SVneo cells (n ¼ 6) and EVT (n ¼ 3). For the HTR-8/SVneo cells, one 2D gel for either the pooled control versus IL11-treated cells was evaluated, and the data indicated that there were differences in the distribution of the GRP78 isoforms within treatments (Fig. 5A) . We then verified this by 2D western blot analysis in primary EVT (n ¼ 3 independent experiments), revealing that out of the five GRP78 immuno-reactive spots, isoform number 3 was more abundant than isoform number 2 in the control EVT lysates (Fig. 5B  and C) , while in the IL11 treated EVT lysates, there was no difference in the relative abundance between isoform numbers 2 and 3. However, there were no significant differences in GRP78 isoforms comparing control and IL11-treated EVT cells directly; this may be due to a small number of biological replicates being available for primary EVT.
IL11 treatment increased the secretion of soluble GRP78
Recent evidence suggested that secretion of different GRP78 isoforms in first-trimester trophoblasts may be associated with shallow trophoblast invasion (Laverriere et al., 2009) . To investigate whether IL11, a repressor of EVT invasion, could be a regulator of GRP78 secretion, we performed western blot analyses of CM from HTR-8/SVneo cells and EVT. IL11 treatment of HTR-8/SVneo cells and primary EVT increased GRP78 protein abundance in CM (Fig. 6A) . Quantification of Western blot data of HTR-8/SVneo cells revealed that IL11 significantly increased GRP78 (370% + 47%) compared with controls (set to 100%) (Fig. 6B) . Similarly, IL11 stimulated the secretion of GRP78 (140 + 3.5%) in primary EVT compared with control (set to 100%) (Fig. 6B) . Notably, the amount of basal levels of secreted GRP78 protein in primary EVT appeared less than those in HTR-8/ SVneo cells as the CM of EVT was concentrated 10-fold compared with non-concentrated CM of HTR8/SVneo cells. To resolve whether the increased secretion of GRP78 via IL11 is connected to the Jak/ STAT3 pathway, we pre-incubated HTR-8/SVneo cells with a specific STAT3 inhibitor (n ¼ 2 independent experiments in duplicate). Inhibition of STAT3 abolished the effect of IL11 on increased GRP78 secretion (control 100%, IL11 251% and iSTAT3 + IL11 57%, Fig. 6C ).
Discussion
In this study, we investigated the proteome of invasive trophoblast cells to identify IL11-regulated proteins using a 2D-DIGE approach. MS analysis revealed several IL11-regulated proteins, two of which were confirmed to be PDIA3 and GRP78. PDIA3 was confirmed to be down-regulated in 1D western blotting in HTR8/SVneo cells and New IL11 target proteins in trophoblasts primary EVT. 2D western blot analysis demonstrated that GRP78 was post-translationally modified. Furthermore, analysis of CM revealed upregulation of GRP78 secretion by trophoblast cells. By utilizing 2D DIGE, we were able to detect post-translational modifications, which could not have been possible if we examined regulation at the mRNA level, highlighting the variability between the transcriptome and the proteome. PDIA3 (also called endoplasmic reticulum protein 57, ERp57) is a member of PDI family and is a GRP (Di Jeso et al., 2005) . It participates in the folding and the disulfide groups shuffling of proteins (Freedman et al., 1994) . PDIA3 is mainly located in the ER but can also be found in the nucleus, extracellular space, cytosol and cell surface (Turano et al., 2002; Chichiarelli et al., 2007) . We have previously demonstrated that IL11 leads to phosphorylation of STAT3 in EVT (Paiva et al., 2009a,b) . Recent studies show a connection between PDIA3 and STAT3 signaling (IL11 main signaling pathway in EVT). PDIA3 is present in STAT3-DNA complexes on the promoter of the human a2-macroglobulin gene in human melanoma M14 cells (Eufemi et al., 2004; Chichiarelli et al., 2010) . Interestingly, the same gene is regulated by IL11/STAT3 signaling in rat uterine stromal cells (Bao et al., 2006) . Another study revealed that downregulation of PDIA3 by siRNA resulted in decreased activation of STAT3. Moreover, experiments using ERp57-deficient cells show that ERp57, from the lumen of the ER, affects STAT3 signaling and functions as a STAT3 inhibitor (Coe et al., 2010) . In the present study, we demonstrated that IL11 down-regulated PDIA3, indicating that IL11 may contribute to a STAT3-PDIA3 negative feed back loop in trophoblast cells, thereby down-regulating PDIA3 protein expression. Functional studies are required to investigate whether a direct interaction and/ or DNA binding of STAT3-PDIA3 occurs and is involved in this process.
The second protein we identified and validated as a target of IL11 was GRP78. GRP78 is an ER chaperone protein belonging to the heat shock protein 70 family. This protein, as the other members of its family, plays an essential role in protein biosynthesis. GRP78 facilitates the folding and assembly of proteins, and prevents intra-or intermolecular aggregation during stress conditions. GRP78 expression is induced by a variety of environmental and physiological stress conditions that affect ER function and homeostasis in order to protect organs and tissues against apoptosis (Lee, 2007) . In our study, stimulation with IL11 did not change the total amount of GRP78 protein abundance. While 1D western blotting showed no regulation of GRP78 in both HTR8/SVneo cells and EVT, 2D western blotting suggested post-translational modification of at least one isoform of GRP78 by IL11. Such changes in protein isoforms may arise in numerous ways-for example, modification by glycosylation (Montes-Sanchez et al., 2009), phosphorylation (Barberis et al., 2009) or proteolytic processing (Kilpatrick et al., 2009) . Similarly, another proteomics study using protein affinity chromatography identified GRP78 in trophoblasts and demonstrated a direct interaction between GRP78 and p53 (Arnaudeau et al., 2009) . The study identified GRP78 as a member of the high molecular weight complexes of p53, which seemed to be involved in p53 stabilization and trophoblast invasion. In that study, decreased expression of membrane GRP78 reduced p53 stability and increased invasion of trophoblast, likely via an altered expression of different matrix metalloproteinases.
The data in the present study further show for the first time that IL11 increased the secretion of GRP78 by EVTs. GRP78 has previously been associated with pregnancy pathologies (Laverriere et al., 2009) . In this study, the investigators conducted that GRP78 cleavage products or GRP78 autoantibodies may be useful markers of defective placental invasion such as that thought to occur in PE. GRP78 levels in sera were compared between healthy pregnant women, women diagnosed with PE and women during the first trimester of pregnancy who subsequently developed PE. There were no differences in total levels of secreted GRP78 between healthy and pre-eclamptic women. By contrast, GRP78 autoantibody levels and the ratio of C-terminal GRP78 over full length secreted GRP78 protein were significantly lower in sera of women during the first trimester who subsequently developed PE compared with sera of women with normal pregnancies. A more recent study, found that decidual IL11 production is increased in women with PE in placental bed biopsies compared with women with normal pregnancy (Basar et al., 2010) . Our findings of elevated levels of secreted GRP78 upon IL11 stimulation could possibly be one of the factors responsible for shallow trophoblast invasion and subsequently abnormal remodeling of spiral arterioles.
Both proteins, PDIA3 and GRP78, identified in this study have also been reported to interact with each other. In oxygen-related stress conditions in cultured endothelial cells, downregulation of PDIA3 increased GRP78 and protected against hyperoxia-induced apoptosis. By contrast, overexpression of PDIA3 decreased GRP78 and reduced protection against apoptosis (Xu et al., 2009) . Our study showed a comparable outcome-IL11 treatment down-regulated PDIA3 while GRP78 secretion was upregulated (Fig. 6) . Additionally, pretreatment with a Stat3 inhibitor abolished the IL11 enhanced secretion of GRP78 by HTR-8/SVneo cells (Fig. 6C) .
In conclusion, we used a proteomics approach to identify IL11 targets in human trophoblast cells and our results suggest that IL11, through activation of STAT3, regulates and modifies proteins that have been associated with placental pathologies. Further studies investigating the mechanistic role of IL11 in trophoblast invasion are needed to explore the functional significance of the proteomic changes and will provide new insights in understanding placental pathologies such as PE.
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